Kyntra Bio
(NASDAQ) FGEN
Kyntra Bio Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$6.44M
Net Income (TTM)
$183.45M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
FGEN News
Why FibroGen Got Mashed on Monday
![Enrique-Conterno[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F552569%2Fenrique-conterno1.jpg&w=3840&op=resize)
FGEN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kyntra Bio
Industry
Biotechnology
Sector
Health CareEmployees
34
CEO
Thane Wettig, MBA
Website
www.fibrogen.comHeadquarters
San Francisco, CA 94158, US
FGEN Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
-7%
Net Income Margin
28%
Return on Equity
-2%
Return on Capital
-51%
Return on Assets
2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$45.90M
EBITDA
$45.90M
Operating Cash Flow
$4.77M
Capital Expenditure
$38.00K
Free Cash Flow
$4.81M
Cash & ST Invst.
$88.98M
Total Debt
$0.00
Kyntra Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.28M
+101.0%
Gross Profit
$2.49M
+102.4%
Gross Margin
1.95%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
225
N/A
Net Income
$14.22M
-179.1%
EBITDA
$9.30M
+89.8%
Quarterly Fundamentals
Net Cash
$88.98M
+324.2%
Accounts Receivable
$216.00K
-55.1%
Inventory
$3.74M
+18.6%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
1.53%
N/A
Return on Invested Capital
-50.80%
N/A
Free Cash Flow
$18.33M
+40.1%
Operating Cash Flow
$18.33M
+39.8%